Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Hohl

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|May 17, 2007
Clinical pharmacology: bridging discovery and practiceR J Hohl
Clinical Pharmacology and Therapeutics|October 23, 2014
Drug development (and academic medicine): charting the course forwardR J Hohl
Clinical Pharmacology and Therapeutics|July 10, 2016
Anticoagulants: Major Advances Without Clear ConsensusR J Hohl
Advances in Experimental Medicine and Biology|January 1, 1996
Monoterpenes as regulators of malignant cell proliferationR J Hohl
Clinical Pharmacology and Therapeutics|February 17, 2015
Oncology trial design: More accurately and efficiently advancing the fieldR J Hohl
The Journal of Biological Chemistry|July 21, 1995
Differential effects of monoterpenes and lovastatin on RAS processingR J Hohl, K Lewis
Hematology/Oncology Clinics of North America|June 1, 1989
Nonmalignant complications of therapy for Hodgkin's diseaseR J Hohl, R L Schilsky
Clinical Pharmacology and Therapeutics|July 22, 2009
Vascular medicine: a look forwardS A Holstein, R J Hohl
Clinical Pharmacology and Therapeutics|December 20, 2011
Therapeutic additions and possible deletions in oncology in 2011S A Holstein, R J Hohl
Molecular Cancer Therapeutics|December 7, 2002
Synergistic interaction of lovastatin and paclitaxel in human cancer cellsS A Holstein, R J Hohl
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|May 17, 2007
Clinical pharmacology: bridging discovery and practiceR J Hohl
Clinical Pharmacology and Therapeutics|October 23, 2014
Drug development (and academic medicine): charting the course forwardR J Hohl
Clinical Pharmacology and Therapeutics|July 10, 2016
Anticoagulants: Major Advances Without Clear ConsensusR J Hohl
Advances in Experimental Medicine and Biology|January 1, 1996
Monoterpenes as regulators of malignant cell proliferationR J Hohl
Clinical Pharmacology and Therapeutics|February 17, 2015
Oncology trial design: More accurately and efficiently advancing the fieldR J Hohl
The Journal of Biological Chemistry|July 21, 1995
Differential effects of monoterpenes and lovastatin on RAS processingR J Hohl, K Lewis
Hematology/Oncology Clinics of North America|June 1, 1989
Nonmalignant complications of therapy for Hodgkin's diseaseR J Hohl, R L Schilsky
Clinical Pharmacology and Therapeutics|July 22, 2009
Vascular medicine: a look forwardS A Holstein, R J Hohl
Clinical Pharmacology and Therapeutics|December 20, 2011
Therapeutic additions and possible deletions in oncology in 2011S A Holstein, R J Hohl
Molecular Cancer Therapeutics|December 7, 2002
Synergistic interaction of lovastatin and paclitaxel in human cancer cellsS A Holstein, R J Hohl
Pageof 5